Radiopharmaceuticals

DATrace-123 is a ready-to-inject solution containing the active substance ioflupane (123I). DATrace-123 is indicated for SPECT imaging of dopamine transporters (DaT) and serotonin transporters due to its excellent ability to combine with both of these compounds.
Active Ingredient: N-13-Fluoropropyl)-2β-carbomethoxy-3β-(4-[123I]iodophenyl)nortropane (123I-ioflupone)

CHARACTERISTICS

• DATrace-123 and Dopamine Transporter SPECTs which use DATrace-123 have been recognized for their effectiveness and stability
• DATrace-123 is comparable to DaTscanTM
• The combination of DATrace-123 with Dopamine Transporter striatum forms a sustained equilibrium, resulting in superb Dopamine Transporter imaging accuracy
• The combination of DATrace-123 with Dopamine Transporter striatum forms a sustained equilibrium, resulting in superb Dopamine Transporter imaging accuracy
• Long half-life (13.2 hours)
• No restriction on the number of patients who can qualify for a one-day exam